antinuclear antibodies were demonstrated in the sera of 43 of 45 ( 96 % ) patients with progressive systemic sclerosis ( 22 of 24 with diffuse scleroderma and 21 of 21 with the crest syndrome variant ) .
C0036421
diffuse scleroderma
C0206138
crest syndrome